There is disclosed an edible emulsion comprising at least two differently formulated aqueous phases containing microbiologically labile nutrients and ingredients inhibiting bacterial growth, said aqueous phases being present in the form of discrete, differently formulated drops dispersed in a continuous phase, wherein an effective amount of each ingredient inhibiting bacterial growth is concentrated along with a nutrient in part of the dispersed aqueous drops and none of the nutrients is present unprotected.
|
1. An edible emulsion comprising at least two differently formulated aqueous phases containing microbiologically labile nutrients and ingredients inhibiting bacterial growth, said aqueous phases being present in the form of discrete, differently formulated drops dispersed in a continuous plastic fat phase, wherein an effective amount of each ingredient inhibiting bacterial growth is concentrated along with a nutrient in at least part of the total aqueous phase and none of the nutrients is present unprotected.
2. An edible emulsion according to
3. An edible emulsion according to
4. An edible emulsion according to
5. An edible emulsion according to
6. An edible emulsion according to
7. An edible emulsion according to
9. An edible emulsion according to
10. An edible emulsion according to
11. A process for producing an edible emulsion according to
12. A process according to
13. A process according to
14. A process according to
15. A process according to
16. A process according to
17. A process according to
18. A process according to
20. A process according to
(a) producing at least two separate emulsions by separately dispersing each of said differently formulated aqueous phases in a plastic fatty phase; (b) separately cooling and texturizing said emulsions; (c) mixing the texturized emulsions by applying a mild shear regime preventing coalescence and intermixing of the differently formulated, dispersed aqueous phases.
21. A process according to
22. A process according to
23. A process according to
24. A process according to
|
The present invention relates to an edible emulsion, particularly a water-in-oil emulsion-spread with a reduced fat content which displays an improved shelf stability.
By reduced fat content is understood a level of fat lower than about 85%, and preferably ranging from 30 to 65 by weight.
Water-containing spreads have a limited shelf stability unless specific measures are taken such as adding water-activity depressing agents, acids, preservatives or gelling agents. Adding said ingredients has however disadvantages. Some of them affect the organoleptic properties of the product when the concentration is too high, others increase too much the cost price of the product and last but not least the use of some ingredients is subject to legal restrictions.
There is need of a spread having an improved shelf stability and good organoleptic properties.
According to the present invention an edible emulsion is provided comprising at least two differently formulated aqueous phases containing microbiologically labile nutrients and ingredients inhibiting bacterial growth, said aqueous phases being present in the form of discrete, differently formulated drops dispersed in a continuous phase, wherein an effective amount of each ingredient inhibiting bacterial growth is concentrated along with a nutrient in part of the dispersed aqueous drops and none of the nutrients is present unprotected.
The present invention particularly relates to water-in-oil emulsion-spreads wherein the differently formulated aqueous phases are dispersed in a continuous plastic fat phase, i.e. a fat phase which contains sufficient crystallized fat at ambient temperature to obtain a spread which can be packed in a tub or in a wrapper. Said continuous fat phase preferably constitutes 30-65% by weight of the total emulsion. Below 30 wt.% of fat the level of aqueous phase will be relatively high and microbiological stabilisation difficult to achieve. In spreads with a level of fat above 65 wt.% the principle of the present invention can perfectly be applied but is less relevant, since microbiological stability is less of a problem and it can be achieved by simpler means.
In the case where intermingling and coalescence of the differently formulated drops of aqueous phases constitute a problem after a long period of storage or during transport, it is important that the emulsion contains an ingredient, for instance an emulsifier, preventing intermingling and coalescence of the drops.
This can be achieved by electrostatic repulsion, or by a component imparting steric hindrance thereby preventing dispersed drops to collide and coalesce, or by applying specific processing conditions as illustrated further in the specification. A particularly useful class of emulsifiers in that respect are the polyglycerol fatty acid esters.
The microbiologically labile nutrients in the emulsions according to the invention may comprise proteins such as milk proteins or vegetable proteins, carbohydrates such as glucose, lactose or products obtained by partially hydrolysing starch.
Ingredients inhibiting bacterial growth may consist of acids such as hydrochloric acid, acetic acid, lactic acid, phosphoric acid; preservatives such as benzoic acid, sorbic acid; water-activity depressing agents such as salts e.g. sodiumchloride, alkali metal phosphates or any substance increasing the osmotic pressure.
According to a specific embodiment of the present invention one aqueous phase is present in the form of discrete drops (i) containing a salt and a nutrient and another aqueous phase is present in the form of discrete drops (ii) containing an acid and a nutrient.
The preferred salt is sodium chloride and its preferred concentration is 6-12 wt.% (based on aqueous phase (i). The acid present in drops (ii) is present in a concentration sufficient to achieve a pH ranging from 1.5 to 5.5, preferably from 2.0 to 4.7.
Nutrients are preferably put together with compatible ingredients inhibiting bacterial growth i.e. ingredients which do not substantially affect the physical or chemical nature of the nutrients or, put in other words, ingredients which do not cause degradation of the nutrients.
According to an embodiment of the present invention a protein is present as one of the nutrients in drops (i), i.e. the drops containing salt and no acid, in order to avoid possible denaturation of the protein.
However, in the case where whey protein is used, a lower pH is also acceptable, e.g. a pH between 3.0 and 4.7.
Water-soluble or -dispersible components, particularly nutrients of the emulsion, are concentrated in a proportion of the total amount of the aqueous phase, e.g. 5-75% of the total amount of the aqueous phase, whereby especially at the lower end of the range the concentration of solutes could be such that no additional specific bacterial growth inhibiting agents are required because of the prevailing, low water-activity.
It is also possible that the spread comprises further drops (iii) of a third aqueous phase which is substantially free from nutrients and ingredients inhibiting bacterial growth, and may consist of pure water.
The porportion of each of the various aqueous phases can vary within a wide range e.g. from 5-75%. It is however preferable to select proportions allowing the presence of a relatively high concentration of the water-activity depressing agent e.g. the salt or of the acid in that part of the aqueous phase where it is most required, while maintaining its overal concentration in the total emulsion within the range dictated by organoleptic considerations.
The present invention also provides a process for producing emulsions as defined hereinbefore, comprising: dispersing in a continuous phase at least two differently formulated aqueous phases containing microbiologically labile nutrients and ingredients inhibiting bacterial growth, in the form of discrete, differently formulated drops, while ensuring that an effective amount of each ingredient inhibiting bacterial growth is concentrated along with a nutrient in part of the dispersed aqueous drops and that none of the nutrients is present unprotected. The protection confered on the nutrients can be attributable to the addition of any of the ingredients inhibiting growth described above or to a high degree of dispersion i.e. a droplet size of less than 5 microns and preferably less than 2 microns.
A preferred way of producing spreads according to the invention involves: (a) producing at least two separate differently formulated aqueous phases wherein in each of said phases a nutrient and an ingredient inhibiting bacterial growth is concentrated; (b) dispersing each of said aqueous phases in a plastic fat phase to obtain at least two separate emulsions, (c) separately cooling and texturising said emulsions, preferably in a Votator-apparatus; and (d) mixing the texturised emulsions applying a mild shear regime, preferably in a static mixer, to prevent intermingling of the various differently formulated aqueous phase-drops.
Each of the aqueous phases may contain one or more nutrients and one or more ingredients inhibiting bacterial growth, which are compatible with the nutrients.
According to a preferred method of performing the process according to the invention a further step (e) is included, involving recirculating each of the emulsions obtained in step (c) into separate containers, prior to intermixing the emulsions in step (d).
It is also possible to carry out a process comprising a further recirculation step (f) involving recirculation as a single phase of at least one of the aqueous phases into separate containers prior to emulsification and intermixing.
This procedure is particularly useful when the aqueous phase consists of a cream which cannot tolerate over-working, which may occur in the case where recirculation has to be carried out, e.g. when the packaging machine breaks down.
The emulsions as hereinbefore described, which ar obtainable according to a process as described above, display an improved microbiological stability in comparison with emulsions wherein the bacterial growth inhibiting ingredients are homogeneously distributed in one single aqueous phase dispersed in the continuous phase. Put in other words: an improved shelf stability is achieved according to the invention at overall levels of the bacterial growth inhibiting ingredients which are equal to or even smaller than the normal levels of the same ingredients.
The invention will now be illustrated in the following example.
A fat spread (40% fat) was produced from two aqueous phase.
The first aqueous phase (25 wt.% of the total amount of the aqueous phases) contained 3.3% of whey protein, 8.0% of sodium chloride and 10.7% of Na2 HPO4 and had a pH of 7∅ (All proportions are based on the weight of this aqueous phase).
The second aqueous phase (75% of the total amount of the aqueous phase) contained 3.0% of 1M hydrochloric acid, 0.2% of citric acid, 0.02% of potassium sorbate and 3.3% of whey protein. The pH was 3∅ (All proportions are based on the weight of this aqueous phase).
The first aqueous phase was emulsified in a margarine fat blend consisting of 23% of palm oil hydrogenated to m.p.=43°C, 77% of soybean oil and 2% of an emulsifier consisting of a polyglycerol ester (Homodan PT).
The second aqueous phase was emulsified separately in in the same blend.
Both emulsions were separately cooled and texturized in a Votator apparatus.
The texturized emulsions were combined by gently mixing in a static mixer to obtain the final spread (pH 6.1).
Experimental samples in an accelerated spoilage test were inocculated with about 103 organisms/g, stored at 10°C and compared with control samples produced starting from the same proportions of the nutrients and ingredients inhibiting bacterial growth as outlined above, which were homogeneously distributed over the whole emulsion instead of being concentrated in separate, differently formulated drops. The resulting pH was 6.1.
The control samples had a count of organisms 1000 times greater than the samples according to the invention following storage.
Moran, David P. J., Gould, Grahame, Crossley, Anthony
Patent | Priority | Assignee | Title |
4746524, | Sep 25 1986 | AGRILINK FOODS, INC NY CORPORATION | Microbiologically-resistant sauces and dressings and method for their preparation |
4882187, | Jul 02 1987 | CONOPCO INC , D B A THOMAS J LIPTON COMPANY | Edible spread and process for the preparation thereof |
5223300, | Oct 10 1990 | Koninklejke Brinkers Margarinefabrieken B.V. | Method for preparing a spread containing lactoprotein and/or vegetable protein and thickener |
5554407, | Jan 17 1992 | Van den Bergh Foods Co., Division of Conopco, Inc. | Process for making spreads and spreads made by the process |
5837307, | Jan 17 1992 | Van den Bergh Foods Co., Division of Conopco, Inc. | Process for making spreads |
Patent | Priority | Assignee | Title |
3917859, | |||
4145451, | Apr 27 1977 | Kraft, Inc. | Preservation of low acid food products in the absence of chemical preservatives |
4350970, | Nov 13 1979 | Siemens Aktiengesellschaft | Method for traffic determination in a routing and information system for individual motor vehicle traffic |
4366180, | May 21 1980 | Lever Brothers Company | Process for producing a low-fat oil-in-water-in-oil emulsion |
Executed on | Assignor | Assignee | Conveyance | Frame | Reel | Doc |
Jul 07 1983 | Lever Brothers Company | (assignment on the face of the patent) | / | |||
Aug 22 1983 | GOULD, GRAHAME | Lever Brothers Company | ASSIGNMENT OF ASSIGNORS INTEREST | 004221 | /0478 | |
Aug 22 1983 | CROSSLEY, ANTHONY | Lever Brothers Company | ASSIGNMENT OF ASSIGNORS INTEREST | 004221 | /0478 | |
Aug 22 1983 | MORAN, DAVID P J | Lever Brothers Company | ASSIGNMENT OF ASSIGNORS INTEREST | 004221 | /0478 |
Date | Maintenance Fee Events |
Jun 02 1988 | M173: Payment of Maintenance Fee, 4th Year, PL 97-247. |
Jun 06 1988 | ASPN: Payor Number Assigned. |
Dec 29 1992 | REM: Maintenance Fee Reminder Mailed. |
May 30 1993 | EXP: Patent Expired for Failure to Pay Maintenance Fees. |
Date | Maintenance Schedule |
May 28 1988 | 4 years fee payment window open |
Nov 28 1988 | 6 months grace period start (w surcharge) |
May 28 1989 | patent expiry (for year 4) |
May 28 1991 | 2 years to revive unintentionally abandoned end. (for year 4) |
May 28 1992 | 8 years fee payment window open |
Nov 28 1992 | 6 months grace period start (w surcharge) |
May 28 1993 | patent expiry (for year 8) |
May 28 1995 | 2 years to revive unintentionally abandoned end. (for year 8) |
May 28 1996 | 12 years fee payment window open |
Nov 28 1996 | 6 months grace period start (w surcharge) |
May 28 1997 | patent expiry (for year 12) |
May 28 1999 | 2 years to revive unintentionally abandoned end. (for year 12) |